Please assess the completion status of the following clinical trial:

Trial Title: BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients with OSA treated by nCPAP but still complaining with EDS~* ESS score \> or = 12~Exclusion Criteria:~* patient suffering from insomnia without OSA~* co-existing narcolepsy~* patient with sleep debt not due to OSA~* acute or chronic severe disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BF2.649 (Type: EXPERIMENTAL): BF2.649 capsules dosed at 5mg, 10 mg, 20mg
- Placebo (Type: PLACEBO_COMPARATOR): Capsules of Placebo containing lactose with low, medium and high dosage

Based on this trial design, predict the completion outcome and termination type (if applicable).